DEFINITIVE PROXY STATEMENT

Company

INTEGRATED BIOPHARMA INC

Filed

November 13, 2000

Period of Report

November 22, 2000

Accession Number

0000891554-00-002291

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →